Figure 3From: Aurora kinase B inhibition reduces the proliferation of metastatic melanoma cells and enhances the response to chemotherapy Modification of nuclear morphology following exposure to barasertib-HQPA. BRAF-mutated melanoma cells were exposed to 30 and 300 nM barasertib-HQPA and after three and six days, polynucleate cells were evidenced by ICC (blue: DAPI).Back to article page